PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.66%
Negative revenue growth while WEED.TO stands at 7.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-35.70%
Negative gross profit growth while WEED.TO is at 374.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
20.21%
Positive EBIT growth while WEED.TO is negative. John Neff might see a substantial edge in operational management.
20.21%
Positive operating income growth while WEED.TO is negative. John Neff might view this as a competitive edge in operations.
113.92%
Net income growth 1.25-1.5x WEED.TO's 88.89%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
99.57%
EPS growth similar to WEED.TO's 90.65%. Walter Schloss would assume both have parallel share structures and profit trends.
99.57%
Similar diluted EPS growth to WEED.TO's 90.65%. Walter Schloss might see standard sector or cyclical influences on both firms.
2.42%
Share reduction more than 1.5x WEED.TO's 18.44%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
2.42%
Diluted share reduction more than 1.5x WEED.TO's 18.35%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
81.64%
OCF growth above 1.5x WEED.TO's 5.06%. David Dodd would confirm a clear edge in underlying cash generation.
77.49%
FCF growth above 1.5x WEED.TO's 5.35%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
594.48%
5Y revenue/share CAGR above 1.5x WEED.TO's 137.89%. David Dodd would look for consistent product or market expansions fueling outperformance.
323.94%
3Y revenue/share CAGR above 1.5x WEED.TO's 13.27%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-161.58%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-776.11%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-559.39%
Negative 3Y OCF/share CAGR while WEED.TO stands at 51.14%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
284.96%
Positive 10Y CAGR while WEED.TO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
43.41%
Positive 5Y CAGR while WEED.TO is negative. John Neff might view this as a strong mid-term relative advantage.
-93.73%
Negative 3Y CAGR while WEED.TO is 54.37%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
5088.46%
10Y equity/share CAGR above 1.5x WEED.TO's 554.91%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
710.77%
Positive 5Y equity/share CAGR while WEED.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
47.80%
Positive short-term equity growth while WEED.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.47%
Firm’s AR is declining while WEED.TO shows 12.02%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.35%
Inventory is declining while WEED.TO stands at 2.77%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.72%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.42%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-8.47%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-34.39%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-20.17%
We cut SG&A while WEED.TO invests at 24.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.